CoChat
Sign Up
Cited by 25

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Cortical signatures of cognition and their relationship to Alzheimer’s disease

for the Alzheimer’s Disease Neuroimaging Initiative, Gross, Alden L., Manly, Jennifer J., Pa, Judy, Johnson, Julene K., Park, Lovingly Quitania, Mitchell, Meghan B., Melrose, Rebecca J., Inouye, Sharon K., McLaren, Donald G.·2012·Brain Imaging and Behavior
DOI 10.1007/s11682-012-9180-5PMC PMC3553578
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11682-012-9180-5

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cortical thickness is key to assessing brain atrophy in AD, with age-related decreases closely linked to cognitive and memory impairments as well as AD conversion.

    “Specifically, cortical thickness (CTh) is key to assessing brain atrophy in AD, with age-related decreases closely linked to cognitive and memory impairments [18] as well as AD conversion [21, 22].”

    From Association of APOC1 with cortical atrophy during conversion to Alzheimer’s disease (2025) · cites this paper as [21]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 67

  1. Ahn, H. J., Seo, S. W., Chin, J., Suh, M. K., Lee, B. H., …, Na, D. L. (2011). The cortical neuroanatomy of neuropsychological deficits in mild cognitive impairment and Alzheimer’s disease: a surface-based morphometric analysis. Neuropsychologia, 49(14), 3931–3945. · DOI
  2. Bakkour, A., Morris, J. C., & Dickerson, B. C. (2009). The cortical signature of prodromal AD: regional thinning predicts mild AD dementia. Neurology, 72(12), 1048–1055. · DOI
  3. Blennow, K., de Leon, M. J., & Zetterberg, H. (2006). Alzheimer’s disease. Lancet, 368, 387–403. · DOI · Paper page
  4. Brink, T. L., Yesavage, J. A., Lum, O., Heersema, P., Adey, M. B., & Rose, T. L. (1982). Screening tests for geriatric depression. Clinical Gerontologist, 1, 37–44. · DOI
  5. Buckner, R. L. (2004). Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate. Neuron, 44, 195–208. · DOI · Paper page
  6. Buckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., …, Mintun, M. A. (2005). Molecular, structural, and functional characterization of Alzheimer’s disease: evidence for a relationship between default activity, amyloid, and memory. Journal of Neuroscience, 25(34), 7709–7717. · DOI · Paper page
  7. Burggren, A. C., Renner, B., Jones, M., Donix, M., Suthana, N. A., …, Bookheimer, S. Y. (2011). Thickness in entorhinal and subicular cortex predicts episodic memory decline in mild cognitive impairment. International Journal of Alzheimer’s Disease, 2011, 956053. · DOI
  8. Carlson, M. C., Xue, Q., Zhou, J., & Fried, L. P. (2008). Executive decline and dysfunction precedes declines in memory: the women’s health and aging study II. Journal of Gerontology: Series A: Biological, Social, and Medical Sciences, 64A, 110–117. · DOI
  9. Clark, C. M., Davatzikos, C., Borthakur, A., Newberg, A., Leight, S., Lee, V. M., et al. (2008). Biomarkers for early detection of Alzheimer pathology. Neurosignals, 16, 11–18. · DOI
  10. Cox, D. R. (1972). Regression models and life-Tables (with discussion). Journal of the Royal Statistical Society, Series B, 34, 187–220. · DOI · Paper page
  11. Dale, A. M., Fischl, B., & Sereno, M. I. (1999). Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage, 9, 179–194. · DOI · Paper page
  12. Davatzikos, C., Bhatt, P., Shaw, L. M., Batmanghelich, K. N., & Trojanowski, J. Q. (2011). Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiology of Aging, 32(12), 2322 e2319–2327. · DOI
  13. Dickerson, B. C., Fenstermacher, E., Salat, D. H., Wolk, D. A., Maguire, R. P., …, Fischl, B. (2008). Detection of cortical thickness correlates of cognitive performance: reliability across MRI scan sessions, scanners, and field strengths. Neuroimage, 39, 10–18. · DOI · Paper page
  14. Dickerson, B. C., Bakkour, A., Salat, D. H., Feczko, E., Pacheco, J., …, Buckner, R. L. 2009. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detecTable in asymptomatic amyloid-positive individuals. Cerebral Cortex, 19(3), 497–510 (Mar). · DOI · Paper page
  15. Dickerson, B. C., Stoub, T. R., Shah, R. C., Sperling, R. A., Killiany, R. J., …, Detoledo-Morrell, L. (2011). Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology, 76(16), 1395–1402. · DOI
  16. Fischl, B., & Dale, A. M. (2000). Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proceedings of the National Academy of Sciences of the United States of America, 97(20), 11050–11055. · DOI
  17. Fischl, B., Sereno, M. I., & Dale, A. M. (1999a). Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system. NeuroImage, 9(2), 195–207. · DOI · Paper page
  18. Fischl, B., Sereno, M. I., Tootell, R. B., & Dale, A. M. (1999b). High-resolution intersubject averaging and a coordinate system for the cortical surface. Human Brain Mapping, 8(4), 272–284. · DOI · Paper page
  19. Fjell, A. M., Amlien, I. K., Westlye, L. T., & Walhovd, K. B. (2009). Mini-mental state examination is sensitive to brain atrophy in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 28(3), 252–258. · DOI
  20. Fjell, A. M., Walhovd, K. B. Amlien, I., Bjørnerud, A., Reinvang, I., …, Fladby, T. (2008). Morphometric changes in the episodic memory network and tau pathologic features correlate with memory performance in patients with mild cognitive impairment. American Journal of Neuroradiology, 29(6), 1183–1189. · DOI
  21. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-mental state A practical method for grading the mental state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198. · DOI · Paper page
  22. Fox, N. C., Warrington, E. K., Freeborough, P. A., Hartikainen, P., Kennedy, A. M., …, Rossor, M. N. (1996). Presymptomatic hippocampal atrophy in Alzheimer’s disease: a longitudinal MRI study. Brain, 119, 2001–2007. · DOI · Paper page
  23. Good, C. D., Scahill, R. I., Fox, N. C., Ashburner, J., Friston, K. J., …, Frackowiak, R. S. (2002). Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. Neuroimage, 17, 29–46. · DOI
  24. Goodglass, H., & Kaplan, E. (1983). The assessment of aphasia and related disorders. Philadelphia: Lea & Febiger.
  25. Hill, D. (2010). Neuroimaging to assess safety and efficacy of AD therapies. Expert Opinion on Investigative Drugs, 19, 23–26. · DOI
  26. Hinrichs, C., Singh, V., Xu, G., & Johnson, S. (2009). MKL for robust Multi-modality AD Classification. Medical Image Computing and Computer Assisted Intervention, 5762, 786–794.
  27. Hinrichs, C., Singh, V., Xu, G., Johnson, S. C., & Initiative, Alzheimers Disease Neuroimaging. (2011). Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI population. NeuroImage, 55(2), 574–589. · DOI
  28. Hosmer, D. W., & Lemeshow, S. (1999). Applied survival analysis: Regression modeling of time to event data. New York: Wiley.
  29. Hu, L., & Bentler, P. M. (1999). Cutoff criteria for fit indices in covariance structure analysis: conventional versus new alternatives. Structural Equation Modeling, 6, 1–55. · DOI · Paper page
  30. Jack, C. R. Jr., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., …, Trojanowski, J. Q. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurology, 9, 119–128. · DOI · Paper page
  31. Johnson, J. K., Gross, A. L., Pa, J., McLaren, D. G., Park, L. Q., & Manly, J. J., for the Alzheimer’s Disease Neuroimaging Initiative (2012). Longitudinal change in neuropsychological performance using latent growth models: A study of mild cognitive impairment. Brain Imaging and Behavior. · DOI
  32. Johnson, S. C., Schmitz, T. W., Moritz, C. H., Meyerand, M. E., Rowley, H. A., …, Alexander, G. E. (2006). Activation of brain regions vulnerable to Alzheimer's disease: the effect of mild cognitive impairment. Neurobiology of Aging, 27(11), 1604–1612. · DOI
  33. Kaplan, E. L., & Meier, P. (1958). Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457–481. · DOI · Paper page
  34. Karow, D. S., McEvoy, L. K., Fennema-Notestine, C., Hagler, D. J., Jr., Jennings, R. G., Brewer, J. B., et al. (2010). Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease. Radiology, 256, 932–942. · DOI
  35. Kruggel, F., Turner, J., & Muftuler, L. T. (2010). Impact of scanner hardware and imaging protocol on image quality and compartment volume precision in the ADNI cohort. NeuroImage, 49, 2123–2133. · DOI
  36. Lezak, M. D., Howieson, D. B., & Loring, D. W. (2004). Neuropsychological assessment (p. 472). New York: Oxford University Press.
  37. Mayeux, R., & Sano, M. (1999). Treatment of Alzheimer’s disease. The New England Journal of Medicine, 341, 1670–1679. · DOI
  38. McDonald, C. R., McEvoy, L. K., Gharapetian, L., Fennema-Notestine, C., Hagler, D. J., Jr., Holland, D., et al. (2009). Regional rates of neocortical atrophy from normal aging to early Alzheimer disease. Neurology, 73, 457–465. · DOI · Paper page
  39. McEvoy, L. K., Fennema-Notestine, C., Roddey, J. C., Hagler, D. J., Jr., Holland, D., Karow, D. S., et al. (2009). Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology, 251, 195–205. · DOI · Paper page
  40. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA group under the auspices of Department of HHS Task Force on Alzheimer’s disease. Neurology, 34, 939–944. · DOI · Paper page
  41. McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R. Jr., …, Phelps, C. H. (2011). The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement, 7(3), 263–269. · DOI · Paper page
  42. Misra, C., Fan, Y., & Davatzikos, C. (2009). Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. NeuroImage, 44(4), 1415–1422. · DOI · Paper page
  43. Morris, J. C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43(11), 2412–2414. · DOI · Paper page
  44. Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C. R., …, Beckett, L. (2005). Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement, 1(1), 55–66. · DOI · Paper page
  45. Muthén, B. O. (1997). Latent variable modeling with longitudinal and multilevel data. In A. Raftery (Ed.), Sociological methodology (pp. 453–480). Boston: Blackwell.
  46. Muthén, B. O., & Curran, P. J. (1997). General longitudinalmodeling of individual differences in experimental designs: a latent variable framework for analysis and power estimation. Psychological Methods, 2, 371–402. · DOI
  47. Muthén, L. K., & Muthén, B. O. (1998–2010). Mplus user's guide: Sixth Edition. Los Angeles, CA: Muthén & Muthén.
  48. Prabhakaran, V., Nair, V. A., Austin, B. P., La, C., Gallagher, T. A., Wu, Y., McLaren, D. G., Xu, G., Turski, P., & Rowley, H. (2012). Current status and future perspectives of magnetic resonance high-field imaging: A summary. Neuroimaging Clinics of North America, in press. · DOI
  49. Rami, L., Solé-Padullés, C., Fortea, J., Bosch, B., Lladó, A., Antonell, A., Olives, J., Castellví, M., Bartres-Faz, D., Sánchez-Valle, R., & Molinuevo, J. L. (2012). Applying the new research diagnostic criteria: MRI findings and neuropsychological correlations of prodromal AD. International Journal of Geriatric Psychiatry, 27, 127–134. · DOI
  50. Reitan, R. (1958). Validity of the trail making test as an indicator of organic brain damage. Perceptual and Motor Skills, 8, 271–276. · DOI
  51. Rey, A. (1964). L'examen clinique en psychologie. Paris: Presses Universitaires de France.
  52. Rosen, W. G., Mohs, R. C., & Davis, K. L. (1984). A new rating scale for Alzheimer's disease. The American Journal of Psychiatry, 141(11), 1356–1364. · DOI · Paper page
  53. Schott, J. M., Fox, N. C., Frost, C., Scahill, R. I., Janssen, J. C., …, Rossor, M. N. (2003). Assessing the onset of structural change in familial Alzheimer’s disease. Annals of Neurology, 53, 181–188. · DOI
  54. Seeley, W. W., Crawford, R. K., Zhou, J., Miller, B. L., & Greicius, M. D. (2009). Neurodegenerative diseases target large-scale human brain networks. Neuron, 62(1), 42–52. · DOI · Paper page
  55. Shaw, L. M. (2008). PENN biomarker core of the Alzheimer’s disease neuroimaging initiative. Neurosignals, 16, 19–23. · DOI
  56. Shen, L., Qi, Y., Kim, S., Nho, K., Wan, J., …, ADNI. (2010). Sparse bayesian learning for identifying imaging biomarkers in AD prediction. Medical Image Computing and Computer-Assisted Intervention , 13(Pt 3), 611–618. · DOI
  57. Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., …, Phelps, C. H. (2011). Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimers Dement. · DOI · Paper page
  58. StataCorp. (2011). Stata statistical software: Release 12. College Station: StataCorp LP.
  59. Steiger, J. H. (1989). EZPATH: A supplementary module for SYSTAT and SYGRAPH. Evanston: Systat.
  60. Talairach, J., & Tournoux, P. (1988). Co-planar stereotaxic atlas of the human brain. New York: Thieme.
  61. Thompson, P. M., Mega, M. S., Woods, R. P., Zoumalan, C. I., Lindshield, C. J., …, Toga, A. W. (2001). Cortical change in Alzheimer’s disease detected with a diseasespecific population-based brain atlas. Cerebral Cortex, 11, 1–16. · DOI
  62. Villemagne, V. L., & Rowe, C. C. (2011). Amyloid imaging. International Psychogeriatrics, 23(Suppl 2), S41–S49. · DOI
  63. Walhovd, K. B., Fjell, A. M., Dale, A. M., McEvoy, L. K., Brewer, J., Karow, D. S., et al. (2010). Multi-modal imaging predicts memory performance in normal aging and cognitive decline. Neurobiology of Aging, 31, 1107–1121. · DOI
  64. Wechsler, D. (1987). Wechsler memory scale-revised. San Antonio: Psychological Corporation.
  65. Weiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., …, Trojanowski, J. Q., Alzheimer’s Disease Neuroimaging Initiative (2012). The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimer’s & Dementia, 8, S1–S68. · DOI
  66. Williams, B. W., Mack, W., & Henderson, V. W. (1989). Boston naming test in Alzheimer’s disease. Neuropsychologia, 27(8), 1073–1079. · DOI
  67. Wolk, D. A., & Dickerson, B. C. (2011). Fractionating verbal episodic memory in Alzheimer's disease. NeuroImage, 54(2), 1530–1539. · DOI

Cited by

Sorted by citations

Metadata

Authors
Initiative, F. T. A. D. N., Gross, A. L., Manly, J. J., Pa, J., Johnson, J. K., Park, L. Q., Mitchell, M. B., Melrose, R. J., Inouye, S. K., & McLaren, D. G.
Venue
Brain Imaging and Behavior
Publisher
Springer Science and Business Media LLC
Published
2012-06-21
Volume
6
Issue
4
Pages
584-598
ISSN
  • 1931-7557
  • 1931-7565
DOI
10.1007/s11682-012-9180-5
PMC
PMC3553578
Cited by
25
References
6
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review